BIN2 Antikörper (AA 290-496) (HRP)
-
- Target Alle BIN2 Antikörper anzeigen
- BIN2 (Bridging Integrator 2 (BIN2))
-
Bindungsspezifität
- AA 290-496
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BIN2 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Bridging integrator 2 protein (290-496AA)
- Isotyp
- IgG
- Top Product
- Discover our top product BIN2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- BIN2 (Bridging Integrator 2 (BIN2))
- Andere Bezeichnung
- BIN2 (BIN2 Produkte)
- Synonyme
- BRAP-1 antikoerper, BIN2 antikoerper, bin2l antikoerper, wu:fi05e01 antikoerper, zgc:55758 antikoerper, bridging integrator 2 antikoerper, bridging integrator 2b antikoerper, BIN2 antikoerper, Bin2 antikoerper, bin2b antikoerper
- Hintergrund
-
Background: Promotes cell motility and migration, probably via its interaction with the cell membrane and with podosome proteins that mediate interaction with the cytoskeleton. Modulates membrane curvature and mediates membrane tubulation. Plays a role in podosome formation. Inhibits phagocytosis.
Aliases: BIN2 antibody, BRAP1Bridging integrator 2 antibody, Breast cancer-associated protein 1 antibody
- UniProt
- Q9UBW5
-